MedPacto Revenue

In the year 2025, MedPacto had annual revenue of 3.90B KRW. MedPacto had revenue of 1.43B in the quarter ending December 31, 2025.

Revenue

3.90B

Revenue Growth

n/a

P/S Ratio

48.27

Revenue / Employee

n/a

Employees

n/a

Market Cap

188.17B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.90B	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Macrogen	195.27B
Vaxcell-Bio Therapeutics	1.90B
ENCell	5.26B
Amicogen	41.98B
Genexine	5.81B
EASY BIO,Inc.	476.94B
JETEMA,	76.90B
iNtRON Biotechnology	5.74B

Revenue Rankings